R Tournegros, B Coulombeau, D Alayadhi, M Fieux, M Auroy, P Céruse, A R Pérouse, P Philouze
{"title":"Bamboo nodes: Retrospective study of 44 patients.","authors":"R Tournegros, B Coulombeau, D Alayadhi, M Fieux, M Auroy, P Céruse, A R Pérouse, P Philouze","doi":"10.1016/j.anorl.2026.09.003","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Bamboo nodes (BNs) are rare inflammatory lesions of the vocal folds, often associated with autoimmune disease. The aim of this study was to identify epidemiological characteristics and treatments in a case series.</p><p><strong>Material and methods: </strong>Retrospective multicenter chart review of patients with suspected BNs between 1986 and 2020.</p><p><strong>Results: </strong>Forty-four patients met the inclusion criteria. All were female. Mean age at diagnosis was 44 years (±11). BNs were mostly bilateral but 5% of patients presented unilateral forms. Sixty-four percent of patients (28/44) were known to have autoimmune disease (AID), while AID was diagnosed secondary to the discovery of BNs in 18% (5/28). All patients received speech therapy. Forty-five percent (20/44) underwent surgical resection of the lesion on the most affected vocal fold. Ten percent of these (2/20) required secondary surgery on the contralateral fold. Mean follow-up after first consultation was 15 months. Sixty-seven percent of patients reported improvement after treatment. Dysphonia improved in 55% of patients who were operated on (11/20), and remained stable in 15% (3/20); the others were lost to follow-up (6/20). Dysphonia improved in 31% of patients who received exclusive speech therapy (5/16), remained stable in 6% (1/16), and worsened for 6% (1/16); 56% of these patients (9/16) were lost to follow-up.</p><p><strong>Conclusions: </strong>This series confirms the main data in the literature. It highlights the interest of screening for an underlying autoimmune condition.</p>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Annals of Otorhinolaryngology-Head and Neck Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.anorl.2026.09.003","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Bamboo nodes (BNs) are rare inflammatory lesions of the vocal folds, often associated with autoimmune disease. The aim of this study was to identify epidemiological characteristics and treatments in a case series.
Material and methods: Retrospective multicenter chart review of patients with suspected BNs between 1986 and 2020.
Results: Forty-four patients met the inclusion criteria. All were female. Mean age at diagnosis was 44 years (±11). BNs were mostly bilateral but 5% of patients presented unilateral forms. Sixty-four percent of patients (28/44) were known to have autoimmune disease (AID), while AID was diagnosed secondary to the discovery of BNs in 18% (5/28). All patients received speech therapy. Forty-five percent (20/44) underwent surgical resection of the lesion on the most affected vocal fold. Ten percent of these (2/20) required secondary surgery on the contralateral fold. Mean follow-up after first consultation was 15 months. Sixty-seven percent of patients reported improvement after treatment. Dysphonia improved in 55% of patients who were operated on (11/20), and remained stable in 15% (3/20); the others were lost to follow-up (6/20). Dysphonia improved in 31% of patients who received exclusive speech therapy (5/16), remained stable in 6% (1/16), and worsened for 6% (1/16); 56% of these patients (9/16) were lost to follow-up.
Conclusions: This series confirms the main data in the literature. It highlights the interest of screening for an underlying autoimmune condition.
期刊介绍:
European Annals of Oto-rhino-laryngology, Head and Neck diseases heir of one of the oldest otorhinolaryngology journals in Europe is the official organ of the French Society of Otorhinolaryngology (SFORL) and the the International Francophone Society of Otorhinolaryngology (SIFORL). Today six annual issues provide original peer reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches and review articles giving most up-to-date insights in all areas of otology, laryngology rhinology, head and neck surgery. The European Annals also publish the SFORL guidelines and recommendations.The journal is a unique two-armed publication: the European Annals (ANORL) is an English language well referenced online journal (e-only) whereas the Annales Françaises d’ORL (AFORL), mail-order paper and online edition in French language are aimed at the French-speaking community. French language teams must submit their articles in French to the AFORL site.
Federating journal in its field, the European Annals has an Editorial board of experts with international reputation that allow to make an important contribution to communication on new research data and clinical practice by publishing high-quality articles.